Back to DE D. E. Shaw & Co., Inc.

KYTXKYTX
3 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in KYVERNA THERAPEUTICS INC

Yes. D. E. Shaw holds 469,346 shares of KYTX (Kyverna Therapeutics), worth $4.2M, as of its Q2 2026 13F filing. It reduced the position by 252,235 shares (-35.0%) from Q1 2026. D. E. Shaw has held KYTX since Q4 2025, across 3 quarterly 13F filings.

Current Value

$4.2M

Current Shares

469,346

Total Value Change

-$692,141

Total Shares Change

-49,166

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
469,346
-35.0%
$4.2M0.0%$8.91
0
2026-Q1
Increased
721,581
+39.2%
$6.2M0.0%$8.63
36
2025-Q4
New
518,512
-
$4.9M0.0%$9.40
37

Other major holders of KYTX: RTW INVESTMENTS, LP, JENNISON ASSOCIATES LLC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used